FDA SBIR Phase I grant awarded to Triple Ring Technologies
Retrieved on:
Tuesday, October 19, 2021
Graphics processing unit, Food and Drug Administration, Government, Hand, HHS, Medtech, Computer-aided design, GPU, Graphics, Silicon, Multimedia, CAD, Spectrometer Telescope for Imaging X-rays, Unitary state, FDA, NIH, Sterilization, U.S. Department of Defense Strategy for Operating in Cyberspace, Office of Inspector General, U.S. Department of Health and Human Services, Computer-aided, Food, Photonics, SBIR, Physics, Triple, Pharmaceutical industry, Medical device
NEWARK, Calif., Oct. 19, 2021 /PRNewswire/ --Triple Ring Technologies, a co-development firm that helps innovators and entrepreneurs develop breakthrough science-based technologies, is pleased to announce that the company has been awarded an SBIR Phase I grant by the Food and Drug Administration entitled An e-beam sterilization dose map simulation tool.
Key Points:
- NEWARK, Calif., Oct. 19, 2021 /PRNewswire/ --Triple Ring Technologies, a co-development firm that helps innovators and entrepreneurs develop breakthrough science-based technologies, is pleased to announce that the company has been awarded an SBIR Phase I grant by the Food and Drug Administration entitled An e-beam sterilization dose map simulation tool.
- The simulation tool scores the dose distribution on a GPU, as well as implements the physics of radiation sterilization", said Dr. Funk, Sr. Director, Photonics, Imaging & X-Ray at Triple Ring Technologies.
- Triple Ring Technologies is a co-development company headquartered in Silicon Valley, with offices inBoston,Toronto, andCopenhagen.
- For more information about Triple Ring Technologies' capabilities, please visit www.tripleringtech.com .